Buckman K and Gutierrez J, et al. Effects of collagen type II for subjective pain relief. Applied health solutions 1999;
Cathcart, E. S., Hayes, K. C., Gonnerman, W. A., Lazzari, A. A., and Franzblau, C. Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab Invest 1986;54(1):26-31. View abstract.
Garnero, P., Gineyts, E., Christgau, S., Finck, B., and Delmas, P. D. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum 2002;46(1):21-30. View abstract.
Garnero, P., Landewe, R., Boers, M., Verhoeven, A., Van Der Linden, S., Christgau, S., Van Der Heijde, D., Boonen, A., and Geusens, P. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002;46(11):2847-2856. View abstract.
Hauselmann, H. J., Caravatti, M., Seifert, B., Wang, K., Bruckner, P., Stucki, G., and Michel, B. A. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial. Br J Rheumatol 1998;37(10):1110-1117. View abstract.
McKown, K. M., Carbone, L. D., Kaplan, S. B., Aelion, J. A., Lohr, K. M., Cremer, M. A., Bustillo, J., Gonzalez, M., Kaeley, G., Steere, E. L., Somes, G. W., Myers, L. K., Seyer, J. M., Kang, A. H., and Postlethwaite, A. E. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arthritis Rheum 1999;42(6):1204-1208. View abstract.
Nandakumar, K. S., Backlund, J., Vestberg, M., and Holmdahl, R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res Ther 2004;6(6):R544-R550. View abstract.
Nissim, A., Winyard, P. G., Corrigall, V., Fatah, R., Perrett, D., Panayi, G., and Chernajovsky, Y. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum 2005;52(12):3829-3838. View abstract.
Sewell, K. L. and Trentham, D. E. Pathogenesis of rheumatoid arthritis. Lancet 1-30-1993;341(8840):283-286. View abstract.
Sieper, J and Mitchison, AN. Therapy with oral collagen type II as new possibility for selective immunosuppression in the therapy of rheumatoid arthritis. Zeitschrift fuer Rheumatologie 1994;53(2):53-58.
Trentham DE, Halpner AD, Trentham RA, Bagchi M, Kothari S, Preuss HG, and Bagchi D. Use of undenatured type II collagen in the treatment of rheumatoid arthritis. Clinical Practice of Alternative Medicine 2001;2(4):254-9.
Trentham, D. E., Dynesius-Trentham, R. A., Orav, E. J., Combitchi, D., Lorenzo, C., Sewell, K. L., Hafler, D. A., and Weiner, H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 9-24-1993;261(5129):1727-1730. View abstract.
Trentham, D. E., Townes, A. S., and Kang, A. H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 9-1-1977;146(3):857-868. View abstract.
Zhang, L. L., Wei, W., Xiao, F., Xu, J. H., Bao, C. D., Ni, L. Q., and Li, X. F. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis. Arthritis Rheum 7-15-2008;59(7):905-910. View abstract.
AutoImmune Inc. announces phase III trial results for Colloral. URL http://www.autoimmune.com/clinic/coll.html (Accessed 24 October 1999).
Barclay TS, Tsourounis C, McCart GM. Glucosamine. Ann Pharmacother 1998;32:574-9. View abstract.
Barnett ML, Combitchi D, Trentham DE. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum 1996;39:623-8. View abstract.
Barnett ML, Kremer JM, St.Clair W, et al. Treatment of rheumatoid arthritis with oral type II collagen. Arthritis Rheum 1998;41:290-7. View abstract.
Kalden JR, Sieper J. Oral collagen in the treatment of rheumatoid arthritis [editorial]. Arthritis Rheum 1998;41:191-4.
Moskowitz RW. Role of collagen hydrolysate in bone and joint disease.Semin Arthritis Rheum 2000;30:87-99. View abstract.
Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons. Aust N Z J Ophthalmol 1996;24:257-60. View abstract.
Trentham DE. Oral tolerization as a treatment of rheumatoid arthritis. Rheum Dis Clin North Am 1998;24:525-36. View abstract.
Xie Q, Shi R, Xu G, et al. Effects of AR7 Joint Complex on arthralgia for patients with osteoarthritis: results of a three-month study in Shanghai, China. Nutr J. 2008 Oct 27;7:31. View abstract.
